Helicobacter pylori: The Spiral Bacterium Living in Your Stomach

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

This test detects Helicobacter pylori, a spiral bacterium that colonizes the stomach's mucus layer, using noninvasive methods such as a urea breath test or stool antigen test. A positive result indicates active colonization. H. pylori is associated with persistent stomach discomfort, gastritis, peptic ulcers, and, over the long term, gastric cancer risk, so your result may help guide a conversation with your clinician about next steps.

Read more →

Understand what your gut health results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

A focused look at the spiral bacterium living in your stomach

A helicobacter pylori test detects an active infection with H. pylori, a spiral-shaped bacterium that lives in the stomach’s mucus layer and produces urease, an enzyme that breaks down urea. Modern testing is usually noninvasive. The urea breath test uses a small dose of labeled urea; if H. pylori urease is present, labeled carbon dioxide appears in your breath, which is then measured. Stool antigen tests identify bacterial proteins shed into stool. In some cases, endoscopy-based testing is performed, where a tiny tissue sample from the stomach is examined with rapid urease testing, histology, culture, or molecular assays. Blood antibody tests exist, but they cannot distinguish current from past infection and are generally less useful for decision-making.

Why this matters comes down to biology. H. pylori can inflame the stomach lining, disrupt acid regulation, and increase susceptibility to peptic ulcers. It modifies the local immune environment and, in a subset of people over time, contributes to atrophic gastritis and a higher risk of gastric cancer. Detecting an active infection provides a clear, actionable explanation for symptoms like gnawing upper abdominal pain, post-meal fullness, or recurrent ulcers. High-quality evidence supports urea breath and stool antigen tests as accurate tools for diagnosis and for confirming eradication after treatment.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

The symptoms and risks that drive this test

Testing links the organism’s biology to the symptoms you feel. When H. pylori colonizes the stomach, its urease neutralizes local acid microenvironments, helping the bacterium survive while irritating the lining. That irritation can present as dyspepsia, early satiety, nausea that keeps you from enjoying your morning coffee, or more serious problems like bleeding ulcers. Identifying the infection clarifies whether your stomach pain is likely bacterial rather than purely acid-related or stress-related. Tests also help sort out the impact of recent antibiotics, acid suppressors, bismuth compounds, or NSAIDs, all of which can interact with ulcer risk or test performance through changes in bacterial load or mucosal integrity.

Zooming out, knowing your H. pylori status is part of prevention and long-term outcomes. Eradicating an active infection reduces ulcer recurrence and the risk of complications like bleeding. In populations or families with higher gastric cancer risk, a confirmed negative or cleared result contributes to risk reduction over time. Noninvasive tests are well-validated for initial diagnosis and “test of cure.” The goal is not just a single negative report but a pattern over time that aligns with symptom relief and better mucosal health.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

Reading a positive or negative report

Results are typically reported as “positive” or “negative” for active infection, with method-specific details. A urea breath test provides a measured rise in labeled carbon dioxide from baseline that crosses a validated threshold when urease activity is present. Stool antigen tests detect bacterial proteins above or below an assay cutoff. Endoscopic testing may report rapid urease positivity, microscopic evidence of organisms and gastritis, or molecular detection of bacterial genes and resistance markers. In general reference populations, urea breath and stool antigen tests show high accuracy, with sensitivity and specificity often in the 90–95% or higher range for quality assays, which is why guidelines favor them for both diagnosis and confirmation after therapy.

A “negative” noninvasive result suggests no evidence of active infection and aligns with a lower likelihood of peptic ulcer disease driven by H. pylori. That often corresponds biologically to calmer gastric inflammation and more stable acid regulation. A “positive” result indicates active colonization and urease activity, a pattern that helps explain dyspepsia and ulcer risk. Important context: certain situations can shift accuracy. Proton pump inhibitors, antibiotics, and bismuth can temporarily depress bacterial load and lower test sensitivity; recent upper GI bleeding can do the same. Serology may remain positive long after the bacterium is gone, so an isolated antibody result does not prove current infection.

What this test does and does not settle

The most useful view is longitudinal and integrated. If you test positive and later test negative after therapy, you have evidence of eradication and a lower risk of recurrence. Pairing results with related markers and findings — like hemoglobin and ferritin for iron deficiency, or endoscopic features when performed — helps you and your clinician connect the dots between a lab result, the stomach lining’s health, and symptoms. While the science behind H. pylori is robust, test interpretation is still clinical: results guide next steps, but decisions depend on your history, medicines, and risk profile.

Frequently Asked Questions

References

  1. Liou JM, Malfertheiner P, Smith SI, El-Omar EM, Wu MS (2024). 40 years after the discovery of Helicobacter pylori: Towards elimination of H pylori for gastric cancer prevention. *The Lancet*, *403*(10444), 2570-2572. https://doi.org/10.1016/S0140-6736(24)01171-1
  2. Kazemi S, Tavakkoli H, Habizadeh MR, Emami MH (2011). Diagnostic values of Helicobacter pylori diagnostic tests: Stool antigen test, urea breath test, rapid urease test, serology and histology. *Journal of Research in Medical Sciences*, *16*(9), 1097-1104. https://pubmed.ncbi.nlm.nih.gov/22973378/
  3. Jovel J, Patterson J, Wang W, Hotte N, O'Keefe S, Mitchel T, Perry T, Kao D, Mason AL, Madsen KL, Wong GK (2016). Characterization of the gut microbiome using 16S or shotgun metagenomics. *Frontiers in Microbiology*, *7*, 459. https://doi.org/10.3389/fmicb.2016.00459
  4. Lynch SV, Pedersen O (2016). The human intestinal microbiome in health and disease. *New England Journal of Medicine*, *375*(24), 2369-2379. https://doi.org/10.1056/NEJMra1600266
  5. Allaband C, McDonald D, Vázquez-Baeza Y, Minich JJ, Tripathi A, Brenner DA, Loomba R, Smarr L, Sandborn WJ, Schnabl B, Dorrestein P, Zarrinpar A, Knight R (2019). Microbiome 101: Studying, analyzing, and interpreting gut microbiome data for clinicians. *Clinical Gastroenterology and Hepatology*, *17*(2), 218-230. https://doi.org/10.1016/j.cgh.2018.09.017

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey